Download PDF

Other users also viewed these articles

Multidisciplinary Delphi study on residual risk in patients with chronic kidney disease and type 2 diabetes mellitus Alberto Ortiz; Ana Cebrián; Alfonso Soto; Andrés Reyes; Jose Luis Górriz;
10.1016/j.nefroe.2025.501338
Evidence for the use of a nonsteroidal mineralocorticoid receptor antagonist for the treatment of chronic kidney disease Mariana Morais David Pliças; Bernardo Marques da Silva; Edgar Avito Fernandes de Almeida;
Nefrologia (English Version). 2025;45:214-27
Information and consensus document for the detection and management of chronic kidney disease Rafael García-Maset; Jordi Bover; Julián Segura de la Morena; Marian Goicoechea Diezhandino; Jesús Cebollada del Hoyo; Javier Escalada San Martin; Lorenzo Fácila Rubio; Javier Gamarra Ortiz; Jose A. García-Donaire; Lisardo García-Matarín; Sílvia Gràcia Garcia; María Isabel Gutiérrez Pérez; Julio Hernández Moreno; Pilar Mazón Ramos; Rosario Montañés Bermudez; Manuel Muñoz Torres; Pedro de Pablos-Velasco; Manuel Pérez-Maraver; Carmen Suárez Fernández; Salvador Tranche Iparraguirre; José Luis Górriz;
Nefrologia (English Version). 2022;42:233-64